Kohjin Bio Co., Ltd. (TYO:177A)

Kohjin Bio Revenue

Kohjin Bio had revenue of 974.00M JPY in the quarter ending June 30, 2026, a decrease of -20.10%. This brings the company's total for the last twelve months to 4.69B, down -9.45% year-over-year. In the fiscal year ending March 31, 2026, Kohjin Bio had annual revenue of 4.94B, down -5.13%. That makes Kohjin Bio the 31,383rd largest company in the world by revenue and 3,309th in Japan.

• Revenue (ttm): 4.69B
• Revenue Growth: -9.45%
• P/S Ratio: 0.86
• Revenue / Employee: 26.67M
• Employees: 176
• Market Cap: 4.03B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Tissue Culture Business 2.54B 51.4%
• Microbial Business 1.42B 28.8%
• Cell Processing Business 974.78M 19.7%

By Geography

Chart

• Japan 3.96B 80.2%
• China 865.09M 17.5%
• Asia (Excluding China) 109.95M 2.2%
• Europe 450.00K 0.0%

Fiscal year ended Mar 31, 2026 See the full Kohjin Bio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.94B	-267.00M	-5.13%
Mar 31, 2025	5.21B	436.00M	9.14%
Mar 31, 2024	4.77B	28.00M	0.59%
Mar 31, 2023	4.74B	795.00M	20.14%
Mar 31, 2022	3.95B	809.83M	25.81%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error